Bond Rout Eases, Target Fakes Everyone Out, and SpaceX Files for IPO

Bond yields pulled back, three oil tankers crossed the Strait for the first time, and markets decided Wednesday was a good day to be optimistic.

The SpaceX IPO prospectus could land at any moment, and OpenAI is reportedly filing its own in the coming weeks. Today's issue has everything before tonight delivers its next round of headlines.

Starlink — Elon Musk’s fast-growing satellite internet venture — is reportedly gearing up for a $100 billion IPO.

To put that in perspective: that’s 228X larger than Amazon’s IPO.

Legendary investor James Altucher is now revealing how everyday investors could position themselves before it hits the public market — for under $100.

He’s even giving away a FREE ticker symbol for those ready to move early.

Click here to access it now

A major shareholder filed to sell nearly $766 million worth of stock in a travel name up about 84% over the past year, while multiple executives at a mega-cap tech giant exercised options and sold more than $12.5 million combined.

You’re seeing hints of insider selling, but Elite Trade Club Insider readers will see where big holders are using strength and liquidity to take risk off the table.

Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.

A subscription gets you:

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

Stocks bounced on Wednesday as Treasury bond yields pulled back from recent highs and three Chinese oil tankers successfully crossed the Strait of Hormuz overnight, the first vessels to do so since the Iran war began, offering markets a hint of what geopolitical relief could look like.

Target delivered its biggest sales gain in years only to reverse sharply after executives struck a cautious tone on the call, warning that tax-refund-fueled spending has faded and the consumer environment remains unpredictable.

TJX surged after raising its full-year sales and earnings guidance, with profit boosted by fuel hedges against rising energy costs, offering a cleaner read on the resilient discount consumer.

GameStop (NYSE: GME) has increased its stake in eBay to about 6.6%, making its push for the e-commerce company harder to ignore. The move comes after eBay rejected GameStop’s earlier takeover offer.

eBay is the Shortcut

GameStop is no longer just floating an idea. By raising its stake, the company is putting more weight behind a plan that could completely change what it becomes.

When you look past the meme-stock noise, the logic is clear. GameStop wants a bigger digital marketplace, not just a retail chain built around games.

Retail Turnaround Was Too Slow

The company already has brand recognition and a loyal customer base. What it does not have is a massive online marketplace with eBay’s reach, seller network, and strength in collectibles.

That is why the move matters for your read on the business. GameStop is not just trying to repair its old retail model; it is trying to buy its way into a much larger digital future.

A Huge Swing With Real Risk

Buying eBay would be a massive leap. eBay is far larger, more established, and already focused on categories like collectibles, where GameStop also sees opportunity.

For GameStop, the company's implications are big. If you strip it down, this is a business choosing a bold marketplace reset over a slow store-by-store turnaround.

Medtronic (NYSE: MDT) is buying SPR Therapeutics for $650 million in cash, giving the medical device giant a stronger position in chronic pain treatment.

The bigger story is not just the device; it is Medtronic expanding into care that avoids opioids, surgery, and permanent implants.

Pain Care Needs a Middle Option

Chronic pain treatment has long been stuck between medication and invasive procedures. That leaves millions of patients caught between addiction risk and a major medical commitment.

SPR gives Medtronic a cleaner middle lane. When you look at the need for safer pain options, a temporary 60-day treatment starts to look like a much bigger healthcare opportunity.

Medtronic’s Bigger Direction

The acquisition fits a broader company strategy. Medtronic is trying to grow in areas where technology can make treatment less invasive, easier to access, and less intimidating.

That matters for your read on the company. Medtronic is not just adding another pain product; it is widening the front door into one of healthcare’s biggest problems.

A Larger Healthcare Play

Pain care is a massive market, but safer options remain limited. Medtronic now gets a platform that can sit between pills and surgery.

If you strip it down, the implication is clear. Medtronic is building a bigger role in chronic pain by offering patients a gentler first step before more serious treatment.

Global trade is changing as more countries explore payment systems outside the U.S. dollar.

If dollar demand weakens over time, investors may look more closely at gold and other hard-asset opportunities.

A free report explains why some analysts are watching gold-linked assets that may still trade at a discount compared with gold’s recent strength.

See the Free Gold Report.

Tesla (NASDAQ: TSLA) has launched Full Self-Driving Supervised in Lithuania, making it the second European country to allow the system after the Netherlands.

Europe has never been an easy market for self-driving features. Regulators move carefully, test heavily, and do not hand out approvals like free samples at Costco.

When you look at Tesla’s long-term plan, software access matters as much as vehicle sales. A wider rollout gives the company more room to turn cars into upgradeable technology platforms.

Approval Becomes the Real Milestone

Lithuania recognized the Dutch certification, giving Tesla another path forward. Other countries may follow if that approval model keeps gaining traction.

That matters for your read on Tesla. The company is not just trying to sell more cars in Europe; it is trying to make its software part of the driving experience there.

Small Market, Bigger Signal

Lithuania is not Europe’s largest auto market. But small approvals can turn into larger momentum when regulators start recognizing each other’s work.

For Tesla, the company news is bigger than one country. A supervised self-driving rollout in Europe gives the business another way to build value through software, not just vehicle deliveries.

If you care about where Tesla goes next, Europe’s approval path may matter more than the market size of Lithuania itself.

Immunovant [IMVT] $35.49 (+34.99%)

IMVT-1402 achieved a 73% response rate among patients with treatment-resistant rheumatoid arthritis who had already failed JAK inhibitors and anti-TNF drugs. Q4 EPS missed, nobody cared.

At $7.2 billion Buy-rated, the pipeline is earning its valuation one indication at a time, and the Graves’ disease launch is still coming.

Claritev [CTEV] $21.24 (+31.72%)

Claritev beat Q1 estimates with revenue of $244.7 million, set record ACV bookings, and reaffirmed its full-year EBITDA guidance of $605-615 million.

The stock was near its 52-week low before today after a rough year. At $358 million Buy-rated and 12x EBITDA after a 70% collapse from highs, the market is deciding the floor is finally in.

T1 Energy [TE] $8.70 (+26.45%)

T1 Energy beat Q1 estimates, EPS of -$0.08 vs -$0.14 expected, and today got a kicker when Leopold Aschenbrenner’s Situational Awareness LP disclosed a 10 million share position in the company alongside Nvidia and AMD.

The stock has now tripled from late April. It’s still losing money, but the right fund apparently thinks that’s a temporary condition.

Perion Network [PERI] $9.01 (-15.66%)

Perion is a digital ad tech company still rebuilding after losing its Microsoft Bing partnership, and today’s selling reflects continued skepticism about whether its AI ad platform can generate real growth without a major platform anchor. At $357 million Buy-rated, the Street believes there’s value here. The market just hasn’t been convinced yet.

Hasbro [HAS] $88.60 (-8.83%)

Hasbro confirmed that the Q1 10-Q filing will be delayed following a March cybersecurity breach and warned that Q2 results will absorb investigatory costs, along with some shipping revenue delays.

The damage isn’t quantified yet, which is exactly the problem.

Markets don’t enjoy open-ended liability questions on $12.4 billion consumer brands, no matter how resilient the Magic: The Gathering business is.

Everspin Technologies [MRAM] $28.94 (-8.76%)

Everspin tripled in under three weeks after its $40 million defense contract announcement, and today is simply giving some of that back in a classic post-run consolidation session.

No new negative news.

The $676 million Strong Buy-rated company’s defense and data center thesis is intact. What goes up 180% in two weeks occasionally takes a Monday off.

When DeepSeek hit the headlines, Nvidia dropped nearly $600 billion in a single session.

Every investor felt it: What if China just won the AI race? But behind closed doors, America has already fired back — with a hidden project at the same Tennessee lab that built the atom bomb. 40,000 scientists.

A device trillions of times more powerful than anything China has built.

A $100 trillion AI reset on the way. Billion-dollar money manager Louis Navellier has identified the one stock that wins this arms race.

Click here for the name and ticker — free.

*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.